To evaluate whether DNA2 activity inhibition can efficiently target MM cells in vivo, we established a MM xenograft model by transplanting ILF2 ASO–resistant GFP+Luc+ JJN3 cells into NSG mice. This evidence concerns the gene DNA2 and Miyoshi myopathy.